BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24039163)

  • 1. Current treatment and outcome for childhood acute leukemia in Tanzania.
    Kersten E; Scanlan P; Dubois SG; Matthay KK
    Pediatr Blood Cancer; 2013 Dec; 60(12):2047-53. PubMed ID: 24039163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
    Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
    Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
    Inaba H; Fan Y; Pounds S; Geiger TL; Rubnitz JE; Ribeiro RC; Pui CH; Razzouk BI
    Cancer; 2008 Aug; 113(3):522-9. PubMed ID: 18484648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
    Gorman MF; Ji L; Ko RH; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
    Pediatr Blood Cancer; 2010 Sep; 55(3):421-9. PubMed ID: 20658611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved treatment results for childhood acute myeloid leukemia in Taiwan.
    Liang DC; Chan TT; Lin KH; Lin DT; Lu MY; Chen SH; Liu HC; Lin MT; Lee MT; Shu SG; Chang TK; Chen JS; Hsiao CC; Hung IJ; Hsieh YL; Chen RL; Cheng SN; Chang WH; Lee CH; Lin KS
    Leukemia; 2006 Jan; 20(1):136-41. PubMed ID: 16281075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience.
    Kairiene I; Pasauliene R; Lipunova N; Vaitkeviciene G; Rageliene L; Rascon J
    Eur J Pediatr; 2017 Oct; 176(10):1329-1337. PubMed ID: 28812191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
    Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia].
    Li J; Gu LJ; Xue HL; Tang JY; Chen J; Zhao HJ; Chen J; Pan C; Wang YP; Ye H
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):351-4. PubMed ID: 15308014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania.
    Cohler C; Jumanne S; Kaijage J; DuBois SG; Scanlan P; Matthay KK
    Pediatr Blood Cancer; 2016 Mar; 63(3):458-64. PubMed ID: 26529141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].
    Zou Y; Wang H; Chen XJ; Wang SC; Zhang L; Chen YM; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):621-5. PubMed ID: 17278430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience.
    Slats AM; Egeler RM; van der Does-van den Berg A; Korbijn C; Hählen K; Kamps WA; Veerman AJ; Zwaan CM
    Leukemia; 2005 Apr; 19(4):537-44. PubMed ID: 15690069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consolidation of therapy of acute myeloid leukemia with the AML-BFM 93 protocol in children in the Czech Republic].
    Starý J; Gajdos P; Blazek B; Ptoszková H; Hrstková H; Kopecná L; Tousovská K; Hak J; Procházková D; Cerná Z; Jabali Y; Timr P; Vávra V; Sedlácek P; Smísek P; Hrusák O; Michalová K
    Cas Lek Cesk; 2004; 143(4):257-63. PubMed ID: 15218726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
    N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon.
    Muwakkit S; Al-Aridi C; Samra A; Saab R; Mahfouz RA; Farra C; Jeha S; Abboud MR
    Am J Hematol; 2012 Jul; 87(7):678-83. PubMed ID: 22565284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.